ASP Isotopes Inc. $ASPI Shares Bought by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC raised its stake in ASP Isotopes Inc. (NASDAQ:ASPI) by 16.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,400,314 shares of the company’s stock after purchasing an additional 194,034 shares during the period. Exchange Traded Concepts LLC owned 1.26% of ASP Isotopes worth $7,492,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of ASP Isotopes by 37.9% during the third quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock worth $43,451,000 after purchasing an additional 1,241,024 shares during the last quarter. Rovida Investment Management Ltd increased its holdings in ASP Isotopes by 45.5% in the third quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company’s stock valued at $30,688,000 after buying an additional 1,000,000 shares during the last quarter. Geode Capital Management LLC raised its stake in ASP Isotopes by 7.6% during the second quarter. Geode Capital Management LLC now owns 1,348,072 shares of the company’s stock valued at $9,924,000 after buying an additional 94,751 shares in the last quarter. Marshall Wace LLP raised its stake in ASP Isotopes by 3,669.1% during the third quarter. Marshall Wace LLP now owns 1,279,121 shares of the company’s stock valued at $12,305,000 after buying an additional 1,245,184 shares in the last quarter. Finally, Jump Financial LLC bought a new position in ASP Isotopes during the 3rd quarter worth approximately $8,990,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

Insider Buying and Selling

In other ASP Isotopes news, COO Robert Ainscow sold 8,438 shares of ASP Isotopes stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $5.44, for a total value of $45,902.72. Following the completion of the transaction, the chief operating officer directly owned 1,537,817 shares in the company, valued at $8,365,724.48. The trade was a 0.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 14.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several brokerages have recently commented on ASPI. Cantor Fitzgerald started coverage on ASP Isotopes in a research report on Thursday, December 4th. They issued an “overweight” rating and a $13.00 target price for the company. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research note on Monday, December 29th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $13.00.

ASP Isotopes Price Performance

Shares of NASDAQ:ASPI opened at $4.37 on Monday. The company has a quick ratio of 6.10, a current ratio of 6.14 and a debt-to-equity ratio of 1.04. ASP Isotopes Inc. has a fifty-two week low of $3.92 and a fifty-two week high of $14.49. The firm has a 50-day simple moving average of $5.78 and a 200 day simple moving average of $7.25. The company has a market cap of $484.37 million, a PE ratio of -3.36 and a beta of 3.55.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.